Who Paid My Doc
Catherine Hoch
Clinical Nurse Specialist, Family Health Oakhurst, NJ Nurse Practitioner
NPI 1326411604 CMS profile 11073744
1803 State Route 35, Oakhurst, NJ 07755
General payments
$291
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Catherine Hoch of Oakhurst, NJ is reported in the CMS Open Payments database as having received $291 across 11 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 45th percentile of Clinical Nurse Specialist, Family Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $178 | 4 | |
| 2022 | General | $13 | 1 | |
| 2021 | General | $100 | 6 |
Beside peers
- Catherine Hoch
- Clinical Nurse Specialist, Family Health median
- Middle half of Clinical Nurse Specialist, Family Health
- National median
In program year 2025, general payments to Catherine Hoch were reported at $178. Among 164 Clinical Nurse Specialist, Family Health profiles paid that year, the median was $216 and the middle half received between $57 and $492.
Show as a table
| Year | Catherine Hoch | Clinical Nurse Specialist, Family Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $100 | $151 | $46–$400 | $132 |
| 2022 | $13 | $153 | $37–$527 | $149 |
| 2023 | $0 | $139 | $50–$451 | $160 |
| 2024 | $0 | $150 | $46–$571 | $164 |
| 2025 | $178 | $216 | $57–$492 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 12 drugsPart D claims
421
Drug cost
$3,364
Branded share of claims
41.3%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 71 | $1,474 | |
| Doxycycline Hyclate | Generic | 67 | $486 | |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 59 | $470 | |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | Brand | 26 | $237 | |
| Cephalexin | Generic | 50 | $202 | |
| Azithromycin | Generic | 56 | $123 | |
| Amoxicillin | Generic | 21 | $120 | |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | Brand | 18 | $76 | |
| Tobramycin | Generic | 15 | $66 | |
| Mupirocin | Generic | 11 | $39 |
The 10 drugs with the highest cost, of 12 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 52 billing codesPaid by Medicare
$58,589
Medicare patients
523
Services billed
1,162
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 73% | |
| Arthritis | 51% | |
| Ischemic heart disease | 32% | |
| Diabetes | 25% | |
| Depression | 19% | |
| Cancer | 18% | |
| Osteoporosis | 17% | |
| Atrial fibrillation | 16% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
11 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Nurse Specialist, Family Health in New Jersey
Tara Viggiani
Clinical Nurse Specialist, Family Health · Hackensack, NJ
Michelle De Jesus
Clinical Nurse Specialist, Family Health · Waldwick, NJ
Deborah Toole
Clinical Nurse Specialist, Family Health · Camden, NJ
Annette Morales
Clinical Nurse Specialist, Family Health · Bayonne, NJ
Leinina Donnelly
Clinical Nurse Specialist, Family Health · Trenton, NJ
Joanne Ownbey
Clinical Nurse Specialist, Family Health · Turnersville, NJ
Related records
Clinical Nurse Specialist, Family Health in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Nurse Specialist, Family Health
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.